Drug Research
Sterling announces strategic investment in ADC Biotechnology
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based...
News
FDA Grants Fast Track Designation for Remestemcel-L in the...
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States FDA has granted Fast Track designation for remestemcel-L in...
News
Janssen Inc Announces the Initiation of a Rolling Submission...
Janssen Inc. the pharmaceutical companies of Johnson & Johnson, has initiated a rolling submission with Health Canada for its investigational single-dose vaccine candidate for the...
News
EMA receives application for conditional marketing authorisation of COVID-19...
EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID?19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of BNT162b2...
News
Biogen partners with Sage Therapeutics on depression, movement disorder...
Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major depressive disorder (MDD) and postpartum depression (PDD), as well as...
News
AstraZeneca Says Forxiga Approved In Japan For Heart Failure
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care.
HF is...
News
Lonza invests to expand manufacturing capabilities at Oregon site
Lonza AG has announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend, Oregon...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.